Showing results (251-260 of 364) with videos related to

Sort By:
Pageof 37
Leukemia & Lymphoma|August 22, 2015
Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamideLindsey R Lombardi, Christopher G Kanakry, Marianna Zahurak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2017
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant CyclophosphamideShannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Cancer Medicine|May 26, 2022
Race-specific prostate cancer outcomes in a cohort of low and favorable-intermediate risk patients who underwent external beam radiation therapy from 1990 to 2017Sean P Stroup, Audry H Robertson, Kayla C Onofaro, et al.
Genes & Cancer|February 14, 2017
Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K GagAnshu Rastogi, Amina Ali, Shyh-Han Tan, et al.
Oncotarget|November 20, 2019
Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrenceWusheng Yan, Muhammad Jamal, Shyh-Han Tan, et al.
Blood Advances|April 29, 2020
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamideAmy E DeZern, Marianna L Zahurak, Heather J Symons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA FactorsJennifer A Kanakry, Christopher D Gocke, Javier Bolaños-Meade, et al.
Breast Cancer Research and Treatment|May 13, 2018
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trialCesar A Santa-Maria, Aditya Bardia, Amanda L Blackford, et al.
Scientific Reports|April 26, 2017
ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer DevelopmentTaduru L Sreenath, Shiela S Macalindong, Natallia Mikhalkevich, et al.
Scientific Reports|September 8, 2017
Erratum: ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer DevelopmentTaduru L Sreenath, Shiela S Macalindong, Natallia Mikhalkevich, et al.
Pageof 37